Investigation of the pathophysiological functions of SPOP has attracted extensive attention in recent years because of its high mutation frequency in prostate cancer (PCa) (5–15%) and endometrial cancer (EC) (8–10%), two hormone-related cancers [10, 11]. The gene discussed is SPOP; the disease is posterior cortical atrophy.